Stéphane Huet

Stéphane Huet

Auto-generated profile, based on publicly available information

Stéphane Huet

Avignon Université, LIA

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 September 2024
Verified
Book Chapter
Closed access
PDF file
LELiana Ermakova
Liana Ermakova
ESEric SanJuan
Eric SanJuan
SHStéphane Huet
Stéphane Huet
HAHosein Azarbonyad
Hosein Azarbonyad
Giorgio Maria Di NunzioGiorgio Maria Di Nunzio
Giorgio Maria Di Nunzio
JKJaap Kamps
Jaap Kamps

16 March 2023
Verified
Book Chapter
Closed access
PDF file
LELiana Ermakova
Liana Ermakova
ESEric SanJuan
Eric SanJuan
SHStéphane Huet
Stéphane Huet
OAOlivier Augereau
Olivier Augereau
HAHosein Azarbonyad
Hosein Azarbonyad
JKJaap Kamps
Jaap Kamps

20 March 2024
Verified
Book Chapter
Closed access
PDF file
LELiana Ermakova
Liana Ermakova
ESEric SanJuan
Eric SanJuan
SHStéphane Huet
Stéphane Huet
HAHosein Azarbonyad
Hosein Azarbonyad
Giorgio Maria Di NunzioGiorgio Maria Di Nunzio
Giorgio Maria Di Nunzio
JKJaap Kamps
Jaap Kamps

1 January 2018
Verified
Conference Paper
Open access
EPElvys Linhares Pontes
Elvys Linhares Pontes
SHStéphane Huet
Stéphane Huet
TSThiago Gouveia da Silva
Thiago Gouveia da Silva
ALAndréa Carneiro Linhares
Andréa Carneiro Linhares
JTJuan-Manuel Torres-Moreno
Juan-Manuel Torres-Moreno

15 October 1991 in Blood
Verified
Journal Article
Open access
PDF file
NBN Busso
N Busso
SHS Huet
S Huet
ENE Nicodeme
E Nicodeme
JHJ Hiernaux
J Hiernaux
FHF Hyafil
F Hyafil
Tissue factor (TF) is the first factor of the extrinsic pathway of coagulation. Normally, TF is not expressed on the surface of endothelial cells. However, expression of TF can be induced in these cells in response to stimulation by diverse inflammatory mediators such as interleukin-1 beta (IL-1 beta), tumor necrosis factor-alpha (TNF- alpha), lipopolysaccharide (LPS), and phorbol 12-myristate 13-acetate (PMA). We have studied the effect of these mediators on the kinetics of the induction of TF-related procoagulant activity (PCA) on human umbilical vein endothelial cells (HUVECs). PCA is transiently induced on HUVECs, attaining a peak some 4 to 8 hours after addition of inflammatory agents, with maximal accumulation of TF messenger RNA (mRNA) occurring 3 to 5 hours earlier. Because the expression of PCA by treated HUVECs returns to basal levels by 20 to 30 hours, we examined the response of these cells to a second inflammatory stimulus. Continuous incubation of cells with a single inflammatory agent for 24 to 48 hours induces a hyporesponsive state with respect to the reinduction of TF expression by the same agent (14% of the initial stimulation for IL-1 beta, 39% for TNF-alpha 30% for LPS, and 7% for PMA). Such a diminution in PCA was also observed in the levels of TF mRNA. By contrast, pretreatment of HUVECs with one agent did not dramatically affect the reinduction of TF by any of the three other factors. We subsequently focused our attention on the induction of the autologous refractory period by IL-1 beta. De novo protein synthesis was not required during the preincubation of ECs for hyporesponsiveness to be observed. The establishment of the refractory state did not depend on the downmodulation of IL-1 beta receptor affinity or expression. Moreover, pretreatment of HUVECs with IL-1 beta increased prostacyclin (PGI2) production in response to a second stimulation by IL-1 beta, although such cells were unable to reexpress TF under the same conditions. This result suggests that distinct secondary messenger pathways are involved in TF induction and PGI2 synthesis by IL-1 beta in HUVECs.